Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Bill would let assessment panel weigh broader evidence for rare and life‑threatening conditions
Summary
SB 59‑15 would direct the Health Technology Assessment Program to consider clinical trials, peer‑reviewed literature and evidence types typically impractical for rare or life‑threatening diseases, and add technologies recommended in Medicare or national guidelines to the program's prioritized review list.
Senate Bill 59‑15 would change how the state's Health Technology Assessment Program prioritizes and evaluates medical technologies. Committee staff said the bill adds a category for technologies recommended for Medicare populations or by nationally recognized expert treatment guidelines and requires expanded evidence review for life‑threatening or rare diseases.
Sponsor…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
